China detains first U.S. citizen in pharma industry probe

Tracy Staton The Chinese pharma crackdown just keeps on widening. Now, a U.S. citizen has been detained in connection with the corruption probe, Reuters reports. And two more ...

First successful transplant of retinas made from embryonic stem cells

Emily Mullin For the first time, scientists have successfully transplanted light-detecting cells in the retina, grown from embryonic stem cells, into mice–a feat that could eventually ...

IMRIS receives FDA 510K clearance for first ceiling-mounted intraoperative CT solution

barbara.lempert WINNIPEG, July 22, 2013 /CNW/ – IMRIS Inc. (NASDAQ: IMRS; TSX: IM) (“IMRIS” or the “Company”) today announced US Food and Drug Administration ...

Vivus, First Manhattan, and Sarissa Capital Announce Settlement Agreement

mia.burns Reconstituted Slate Will Include Six First Manhattan Nominees and Four VIVUS Nominees Anthony Zook is Expected to Serve as New CEO and to be Appointed to the Board Annual ...

Reuters: Vivus delays proxy vote to negotiate with First Manhattan

Carly Helfand Vivus put its proxy vote on hold for two hours this morning to negotiate with dissident shareholder First Manhattan Co., Reuters reports, citing sources. The ...

First Manhattan sues Vivus for ‘illegally’ delaying shareholder vote

Tracy Staton The company's rebel shareholder sued Vivus for postponing its annual meeting, accusing the board of directors of stalling to keep themselves in office. FiercePharma ...

Industry Voices: A Pivotal Time for Stem Cell Therapeutics, as First Clinical Data Emerges

Alok Saboo For the first time, we have reached the point where clinical data on stem cell therapeutics can be reported, and these early results have been promising, offering a ...

Averica Announces Winner for First Award

mia.burns Averica Discovery Announces Winner of First Averica Award for Supercritical Fluid Chromatography (SFC) — Pfizer’s Bill Farrell Honored for Contributions to Preparative ...

Vivus weighs in with last-ditch effort to beat back First Manhattan contenders

Carly Helfand The eleventh hour for Vivus  is drawing near. Its annual stockholder meeting is Monday, at which time it will find out if proxy brawler First Manhattan ...

Novavax Initiates First Phase 1 Clinical Trial of Its A(H7N9) Influenza Vaccine Candidate

barbara.lempert ROCKVILLE, Md., July 8, 2013 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq:NVAX) today announced that enrollment has begun in a Phase 1 clinical trial of its monovalent ...

Oramed Enrolls First Patient in its Phase 2a U.S. Oral Insulin Clinical Trial

barbara.lempert Marks initiation of Oramed’s first FDA trial for its flagship ORMD-0801 oral insulin product JERUSALEM, July 8, 2013 /PRNewswire/ — Oramed Pharmaceuticals ...

Immunomedics Reports First Results From Phase Ib Study of 90Y-Clivatuzumab

barbara.lempert Immunomedics Reports First Results From Phase Ib Study of 90Y-Clivatuzumab in Patients With Metastatic Pancreatic Cancer After 2 or More Prior Therapies — Repeated ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS